Senthil Sukumar, MD
@SSukumarMD
Followers
295
Following
905
Media
26
Statuses
192
Assistant Prof @BCMHouston. Non-malignant Hematologist. Fellowship @OSUCCC_James. IM Residency @UTSWInternalMed '18. @UMKCmedschool ‘15. Tweets are my own.
Houston, TX
Joined June 2020
TTP survivors face increased cardiovascular risk, but why? Cardiac MRI shows reduced stress myocardial blood flow & perfusion reserve in survivors vs controls. Endothelial dysfunction may play a role in increased CV morbidity & mortality in these patients. https://t.co/sLvLrElF0Q
0
5
12
Oncology is an incredibly rewarding field, but it can also be emotionally heavy. Burnout is real, especially early in your career. Having a strong support system makes all the difference. Grateful for my amazing oncology crew here in Houston—find your people, lean on them! 🤍
3
8
123
0
5
13
@WinnAwards annual meeting this weekend in San Diego! Working to ⬆️ URM clinical trial involvement/accrual and getting to build this strong network of colleagues/friends @BrunaPellini @kspencer725 @SSukumarMD
0
5
14
So stoked to see a companion article with a legendary title from former @UTSWInternalMed @UTSWIMchief co-resident (now full fledged hematologist @bcmhouston ) @SSukumarMD ! @dhjutsw1 @DinoKazi
https://t.co/UFzv3HmVt6
ashpublications.org
In this issue of Blood, Brown et al show that novel therapy with intermediate- to high-dose nonsteroidal antiinflammatory drugs (NSAIDs) overcomes augmente
2
2
3
Out now in @BloodJournal - our paper on NSAIDS in Ghosal syndrome (@BabushokLab @dr_barrett) https://t.co/c7LR2yiSnr
ashpublications.org
Key Points. NSAIDs can normalize hematologic parameters and serum inflammatory markers in patients with Ghosal hematodiaphyseal dysplasia syndrome.Prostagl
1
3
12
Immune thrombotic thrombocytopenic purpura: Spotlight on long-term outcomes and survivorship https://t.co/uggXDoCRR0
@USTMAConsortium @TTPFoundation
1
6
12
Strategies to optimize long term #iTTP outcomes highlighted in our new review. https://t.co/LtHjaQkzol
#TTP #survivorship #RareDisease @TTPFoundation @USTMAConsortium @TTP_Network @SSukumarMD
0
5
13
https://t.co/WxxQksOA7a Registration is officially open for the 2023 USTMA Patient meeting! We hope you can join us to make this first in person event a success! For any questions or concerns, message us or email Clare@USTMA.org
0
4
3
Coming soon! Register for the January 17 webinar on thrombotic microangiopathies. Join Johanna Kremer Hovinga, Spero Cataland and @SSukumarMD for this event. Register here: https://t.co/NTMCkU4PLb
0
8
9
Excited to share our work on novel EHR clinical risk model for predicting #cancer #thrombosis (#VTE). Easy to use. Identifies 70% VTE events in high-risk (6-mo rate 10% vs. 3% in high- vs low-risk) @JCO_ASCO @BCMDeptMedicine @MarcCarrier1 @ChrisRFlowersMD
https://t.co/qgf6JvpvGF
8
30
85
Are you a woman who has had TTP? Researchers are interested in your experiences with care after TTP, especially regarding pregnancy (or deciding whether you want to or should get pregnant). Please take a few minutes to share your perspective with this in this research survey.
3
5
4
Out now- my first first-author paper in @BloodJournal with @BabushokLab @PennCancer – “Non-steroidal anti-inflammatory drugs as a targeted therapy for bone marrow failure in Ghosal Hematodiaphyseal Dysplasia” 🧵 (1/13)
6
11
70
I had been suffering from bruising, extreme tiredness, fast heart rate and shortness of breath. Reeshemah Wynn went to the emergency room with what she thought was the flu, but she was diagnosed with a rare blood disorder called aTTP. Read her story here[ https://t.co/EOQDje5irL]
0
2
3
Ever wondered what to do for #TTP in remission? 🤔 Today in @BloodJournal - how I treat TTP after discharge ⬇️ @USTMAConsortium @HTRSFellows @SSukumarMD @TTP_Network @ttpdoc
https://t.co/KUQRxuTZkK
ashpublications.org
Cataland and colleagues describe a clinical approach to the follow-up of patients with immune-mediated thrombotic thrombocytopenic purpura (iTTP) following
1
13
33
Officially moved Columbus ➡️Houston! Excited to share my start as Assistant Professor Breast Medical Oncology @MDAndersonNews. Immense gratitude to mentors, friends & family for the endless support - looking forward to the next chapter! #bcsm
20
4
173
🚨@USTMAConsortium study 💪 N=645 ✅ Acute #TTP outcomes similar by #race ⬆️ relapse Black pts despite anti-CD20 🔑 Anti-CD20 works; shorter lived effect in Black patients -> may need closer monitoring and retreatment / other IST 🤔 https://t.co/RnQiKnBgJW
@BloodJournal
3
17
78
As I finish out my last month of oncology training I’m so honored to attend #MyFirstASCO with my dad, an outstanding oncologist dedicated to cancer care for 30 years and my inspiration #ASCO22 @ASCO
12
17
324
If you’re living with TTP, we’d love to hear from you! Researchers are looking at TTP patients’ experiences with healthcare to understand if differences in access to care after a TTP diagnosis impact outcomes. Please consider taking this anonymous survey:
0
3
5
🚨BEYOND excited to share our illustrated review published today @RPTHjournal! We tackle the complex topic of thrombotic microangiopathies, a diverse group of unique disorders often w/ high morbidity/mortality that can be challenging to diagnose and treat. https://t.co/TJ6vFkUetD
23
19
159